{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:05:51Z","timestamp":1775041551259,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010166","name":"Xiamen Bureau of Science and Technology","doi-asserted-by":"crossref","award":["3502Z20241001"],"award-info":[{"award-number":["3502Z20241001"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Xiamen Municipal Health Commission","award":["2021ZD01006"],"award-info":[{"award-number":["2021ZD01006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Congenital heart disease (CHD) is the most common birth defect worldwide, affecting approximately 1% of live births. Improving the prenatal diagnosis of CHD remains an urgent clinical priority. In this study, we aimed to screen and validate amniotic fluid methylation biomarkers from clinical cases for the prenatal diagnosis of CHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 135 amniotic fluid samples (80 cases and 55 controls) collected during the second trimester were included and divided into three independent cohorts. Cohort I was used to screen for differentially methylated regions (DMRs) by whole-genome bisulfite sequencing (WGBS) during the discovery phase. The above candidate DMRs were detected using target bisulfite sequencing (TBS) in an independent cohort II. The final biomarker set was selected according to adjusted\n                      <jats:italic>P<\/jats:italic>\n                      -values, sequencing depth, group differences, and relevance to cardiac development and key metabolic pathways. The model was built using individual biomarker cut-off values. Its predictive performance and generalizability were evaluated in an independent cohort III.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      WGBS and unsupervised clustering analysis revealed differential methylation patterns in amniotic fluid DNA between the CHD and normal groups. The 52 DMRs (adj\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) were identified by screening with the above factors. Then, the analysis of cohort II via TBS identified 25 differentially methylated sites. From these, a predictive model was constructed using the four hypermethylated sites with the greatest group differences, all located within a single intron of the\n                      <jats:italic>PCNT<\/jats:italic>\n                      gene. Validation in an independent cohort III identified 11 differentially methylated sites, with an 8-site overlap with cohort II. Notably, 7 of the overlapping sites were associated with\n                      <jats:italic>PCNT<\/jats:italic>\n                      , highlighting strong reproducibility. This model showed consistent and decent performance in the cohort III (specificity: 95.65%, sensitivity: 70.45%), the cohort II (specificity: 73.08%, sensitivity: 83.33%), as well as in simple congenital heart disease (SCHD) (specificity: 83.67%, sensitivity: 76.09%) and complex congenital heart disease (CCHD) sample sets (specificity: 83.67%, sensitivity: 75.00%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      DNA methylation profiles in amniotic fluid differ significantly between fetuses with CHD and normal fetuses. The methylation of\n                      <jats:italic>PCNT<\/jats:italic>\n                      was suggested to be associated with the pathogenesis of CHD. Furthermore, the four-marker methylation panel identified in this study demonstrated decent efficacy in distinguishing fetuses with CHD, highlighting its promise as a new adjunctive diagnostic approach for prenatal CHD in high-risk pregnant women.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-026-02090-4","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:23:25Z","timestamp":1772115805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of DNA methylation biomarkers in amniotic fluid for prenatal detection of congenital heart disease (CHD)"],"prefix":"10.1186","volume":"18","author":[{"given":"Weilun","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qichang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"2090_CR1","doi-asserted-by":"publisher","unstructured":"Zaidi S, Brueckner M. Genetics genomics of congenital heart disease. Circul Res. 2017;120(6):923\u2013. https:\/\/doi.org\/10.1161\/circresaha.116.309140. \u200940.","DOI":"10.1161\/circresaha.116.309140"},{"issue":"6","key":"2090_CR2","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/circresaha.116.309302","volume":"120","author":"BJ Bouma","year":"2017","unstructured":"Bouma BJ, Mulder BJ. Changing landscape of congenital heart disease. Circul Res. 2017;120(6):908\u201322. https:\/\/doi.org\/10.1161\/circresaha.116.309302.","journal-title":"Circul Res"},{"issue":"5","key":"2090_CR3","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/s0735-1097(01)01272-4","volume":"37","author":"CA Warnes","year":"2001","unstructured":"Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37(5):1170\u20135. https:\/\/doi.org\/10.1016\/s0735-1097(01)01272-4.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2090_CR4","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/circulationaha.120.052594","volume":"142","author":"BM Kuehn","year":"2020","unstructured":"Kuehn BM. New Guideline Emphasizes need for life-long care for congenital heart disease. Circulation. 2020;142(23):2276\u20137. https:\/\/doi.org\/10.1161\/circulationaha.120.052594.","journal-title":"Circulation"},{"issue":"23","key":"2090_CR5","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1161\/circulationaha.121.056455","volume":"144","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Chen H, Zhang G, Chen W, Jia B, Liu F, et al. High prevalence of unrecognized congenital heart disease in school-age children in rural China: a population-based echocardiographic screening study. Circulation. 2021;144(23):1896\u20138. https:\/\/doi.org\/10.1161\/circulationaha.121.056455.","journal-title":"Circulation"},{"issue":"2","key":"2090_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/eurjpc\/zwac296","volume":"30","author":"AA Frogoudaki","year":"2023","unstructured":"Frogoudaki AA. Congenital heart disease prevalence: What does the future hold? Eur J Prev Cardiol. 2023;30(2):167\u20138. https:\/\/doi.org\/10.1093\/eurjpc\/zwac296.","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"2090_CR7","doi-asserted-by":"publisher","first-page":"e17745","DOI":"10.15252\/emmm.202317745","volume":"15","author":"YN Yin","year":"2023","unstructured":"Yin YN, Cao L, Wang J, Chen YL, Yang HO, Tan SB, et al. Proteome profiling of early gestational plasma reveals novel biomarkers of congenital heart disease. EMBO Mol Med. 2023;15(12):e17745. https:\/\/doi.org\/10.15252\/emmm.202317745.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2090_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12872-022-02912-2","volume":"22","author":"X Yuan","year":"2022","unstructured":"Yuan X, Li L, Kang H, Wang M, Zeng J, Lei Y, et al. Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis. BMC Cardiovasc Disord. 2022;22(1):495. https:\/\/doi.org\/10.1186\/s12872-022-02912-2.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2090_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/cvr\/cvw195","volume":"112","author":"M Grunert","year":"2016","unstructured":"Grunert M, Dorn C, Cui H, Dunkel I, Schulz K, Schoenhals S, et al. Comparative DNA methylation and gene expression analysis identifies novel genes for structural congenital heart diseases. Cardiovascular Res. 2016;112(1):464\u201377. https:\/\/doi.org\/10.1093\/cvr\/cvw195.","journal-title":"Cardiovascular Res"},{"issue":"8","key":"2090_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg1655","volume":"6","author":"KD Robertson","year":"2005","unstructured":"Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6(8):597\u2013610. https:\/\/doi.org\/10.1038\/nrg1655.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"2090_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/circgenetics.113.000441","volume":"7","author":"S Zaina","year":"2014","unstructured":"Zaina S, Heyn H, Carmona FJ, Varol N, Sayols S, Condom E, et al. DNA methylation map of human atherosclerosis. Circulation Cardiovasc Genet. 2014;7(5):692\u2013700. https:\/\/doi.org\/10.1161\/circgenetics.113.000441.","journal-title":"Circulation Cardiovasc Genet"},{"key":"2090_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12575-019-0107-z","volume":"21","author":"\u0160 \u0160est\u00e1kov\u00e1","year":"2019","unstructured":"\u0160est\u00e1kov\u00e1 \u0160, \u0160\u00e1lek C, Reme\u0161ov\u00e1 H. DNA methylation validation methods: a coherent review with practical comparison. Biol procedures online. 2019;21:19. https:\/\/doi.org\/10.1186\/s12575-019-0107-z.","journal-title":"Biol procedures online"},{"issue":"1","key":"2090_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/15592294.2020.1786318","volume":"16","author":"HR Gosselt","year":"2021","unstructured":"Gosselt HR, Griffioen PH, van Zelst BD, Oosterom N, de Jonge R, Heil SG. Global DNA (hydroxy)methylation is stable over time under several storage conditions and temperatures. Epigenetics. 2021;16(1):45\u201353. https:\/\/doi.org\/10.1080\/15592294.2020.1786318.","journal-title":"Epigenetics"},{"issue":"1","key":"2090_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13148-021-01077-7","volume":"13","author":"J Cao","year":"2021","unstructured":"Cao J, Wu Q, Huang Y, Wang L, Su Z, Ye H. The role of DNA methylation in syndromic and non-syndromic congenital heart disease. Clin epigenetics. 2021;13(1):93. https:\/\/doi.org\/10.1186\/s13148-021-01077-7.","journal-title":"Clin epigenetics"},{"issue":"1","key":"2090_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13148-022-01242-6","volume":"14","author":"\u0160 \u0160est\u00e1kov\u00e1","year":"2022","unstructured":"\u0160est\u00e1kov\u00e1 \u0160, Cerovsk\u00e1 E, \u0160\u00e1lek C, Kundr\u00e1t D, Je\u017e\u00ed\u0161kov\u00e1 I, Folta A, et al. A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel. Clin epigenetics. 2022;14(1):22. https:\/\/doi.org\/10.1186\/s13148-022-01242-6.","journal-title":"Clin epigenetics"},{"issue":"1","key":"2090_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12863-021-00975-2","volume":"22","author":"M Li","year":"2021","unstructured":"Li M, Lyu C, Huang M, Do C, Tycko B, Lupo PJ, et al. Mapping methylation quantitative trait loci in cardiac tissues nominates risk loci and biological pathways in congenital heart disease. BMC genomic data. 2021;22(1):20. https:\/\/doi.org\/10.1186\/s12863-021-00975-2.","journal-title":"BMC genomic data"},{"issue":"2","key":"2090_CR17","doi-asserted-by":"publisher","first-page":"110565","DOI":"10.1016\/j.ygeno.2023.110565","volume":"115","author":"X Yuan","year":"2023","unstructured":"Yuan X, Huang J, Wen L, Novakovic B, Kilby MD, Tong C, et al. Genome-wide DNA methylation analysis of discordant monozygotic twins reveals consistent sites of differential methylation associated with congenital heart disease. Genomics. 2023;115(2):110565. https:\/\/doi.org\/10.1016\/j.ygeno.2023.110565.","journal-title":"Genomics"},{"issue":"9","key":"2090_CR18","doi-asserted-by":"publisher","first-page":"e0203893","DOI":"10.1371\/journal.pone.0203893","volume":"13","author":"U Radhakrishna","year":"2018","unstructured":"Radhakrishna U, Vishweswaraiah S, Veerappa AM, Zafra R, Albayrak S, Sitharam PH, et al. Newborn blood DNA epigenetic variations and signaling pathway genes associated with Tetralogy of Fallot (TOF). PLoS ONE. 2018;13(9):e0203893. https:\/\/doi.org\/10.1371\/journal.pone.0203893.","journal-title":"PLoS ONE"},{"issue":"3","key":"2090_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/epi-2016-0093","volume":"9","author":"KP Wijnands","year":"2017","unstructured":"Wijnands KP, Chen J, Liang L, Verbiest MM, Lin X, Helbing WA, et al. Genome-wide methylation analysis identifies novel CpG loci for perimembranous ventricular septal defects in human. Epigenomics. 2017;9(3):241\u201351. https:\/\/doi.org\/10.2217\/epi-2016-0093.","journal-title":"Epigenomics"},{"issue":"1","key":"2090_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajog.2022.07.062","volume":"228","author":"R Bahado-Singh","year":"2023","unstructured":"Bahado-Singh R, Friedman P, Talbot C, Aydas B, Southekal S, Mishra NK, et al. Cell-free DNA in maternal blood and artificial intelligence: accurate prenatal detection of fetal congenital heart defects. Am J Obstet Gynecol. 2023;228(1):76.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2090_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/bib\/bbz160","volume":"22","author":"L Huang","year":"2021","unstructured":"Huang L, Shao D, Wang Y, Cui X, Li Y, Chen Q, et al. Human body-fluid proteome: quantitative profiling and computational prediction. Brief Bioinform. 2021;22(1):315\u201333. https:\/\/doi.org\/10.1093\/bib\/bbz160.","journal-title":"Brief Bioinform"},{"key":"2090_CR22","doi-asserted-by":"publisher","unstructured":"Cerchietti L, Melnick ADNA. Methylation-based, biomarkers. J Am Soc Clin Oncol. 2017;35(7):793\u20135. https:\/\/doi.org\/10.1200\/jco.2016.71.0616.","DOI":"10.1200\/jco.2016.71.0616"},{"key":"2090_CR23","doi-asserted-by":"publisher","unstructured":"Bahado-Singh RO, Zaffra R, Albayarak S, Chelliah A, Bolinjkar R, Turkoglu O, et al. Epigenetic markers for newborn congenital heart defect (CHD). The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies. Int Soc Perinat Obstet. 2016;29(12):1881\u20137. https:\/\/doi.org\/10.3109\/14767058.2015.1069811.","DOI":"10.3109\/14767058.2015.1069811"},{"issue":"3","key":"2090_CR24","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3892\/etm.2021.10464","volume":"22","author":"J Zhou","year":"2021","unstructured":"Zhou J, Xiong Y, Dong X, Wang H, Qian Y, Ma D, et al. Genome-wide methylation analysis reveals differentially methylated CpG sites and altered expression of heart development-associated genes in fetuses with cardiac defects. Experimental therapeutic Med. 2021;22(3):1032. https:\/\/doi.org\/10.3892\/etm.2021.10464.","journal-title":"Experimental therapeutic Med"},{"key":"2090_CR25","doi-asserted-by":"publisher","unstructured":"Prognosis Grading and Perinatal Risk Assessment of Fetal Heart Disease Expert Panel. Consensus on the medical model and technical process of multidisciplinary diagnosis and treatment and precision integrated prevention and management of fetal heart disease in maternal-fetal medicine (Part I): Expert consensus on prognosis grading and perinatal risk assessment of fetal heart disease. Chin J Perinat Med. 2022;25(05):321-5. https:\/\/doi.org\/10.3760\/cma.j.cn113903-20220323-00281","DOI":"10.3760\/cma.j.cn113903-20220323-00281"},{"issue":"7","key":"2090_CR26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00246-018-1908-6","volume":"39","author":"MN Mat Bah","year":"2018","unstructured":"Mat Bah MN, Sapian MH, Jamil MT, Alias A, Zahari N. Survival and associated risk factors for mortality among infants with critical congenital heart disease in a developing country. Pediatr Cardiol. 2018;39(7):1389\u201396. https:\/\/doi.org\/10.1007\/s00246-018-1908-6.","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"2090_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/jci69942","volume":"124","author":"W Li","year":"2014","unstructured":"Li W, Li Q, Jiao Y, Qin L, Ali R, Zhou J, et al. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Investig. 2014;124(2):755\u201367. https:\/\/doi.org\/10.1172\/jci69942.","journal-title":"J Clin Investig"},{"issue":"6s","key":"2090_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jvs.2017.11.091","volume":"68","author":"T Tanaka","year":"2018","unstructured":"Tanaka T, Kelly M, Takei Y, Yamanouchi D. RANKL-mediated osteoclastogenic differentiation of macrophages in the abdominal aorta of angiotensin II-infused apolipoprotein E knockout mice. J Vasc Surg. 2018;68(6s):48. https:\/\/doi.org\/10.1016\/j.jvs.2017.11.091. S-59S.e1.","journal-title":"J Vasc Surg"},{"issue":"9","key":"2090_CR29","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.stemcr.2022.07.003","volume":"17","author":"BI Garay","year":"2022","unstructured":"Garay BI, Givens S, Abreu P, Liu M, Y\u00fccel D, Baik J, et al. Dual inhibition of MAPK and PI3K\/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes. Stem cell Rep. 2022;17(9):2005\u201322. https:\/\/doi.org\/10.1016\/j.stemcr.2022.07.003.","journal-title":"Stem cell Rep"},{"issue":"12","key":"2090_CR30","doi-asserted-by":"publisher","first-page":"165906","DOI":"10.1016\/j.bbadis.2020.165906","volume":"1866","author":"S Liang","year":"2020","unstructured":"Liang S, Shi X, Yu C, Shao X, Zhou H, Li X, et al. Identification of novel candidate genes in heterotaxy syndrome patients with congenital heart diseases by whole exome sequencing. Biochim et Biophys acta Mol basis disease. 2020;1866(12):165906. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165906.","journal-title":"Biochim et Biophys acta Mol basis disease"},{"issue":"18","key":"2090_CR31","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/circulationaha.106.619213","volume":"114","author":"MF Bijlsma","year":"2006","unstructured":"Bijlsma MF, Peppelenbosch MP, Spek CA. Hedgehog morphogen in cardiovascular disease. Circulation. 2006;114(18):1985\u201391. https:\/\/doi.org\/10.1161\/circulationaha.106.619213.","journal-title":"Circulation"},{"issue":"7453","key":"2090_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature12141","volume":"498","author":"S Zaidi","year":"2013","unstructured":"Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature. 2013;498(7453):220\u20133. https:\/\/doi.org\/10.1038\/nature12141.","journal-title":"Nature"},{"issue":"7553","key":"2090_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nature14269","volume":"521","author":"Y Li","year":"2015","unstructured":"Li Y, Klena NT, Gabriel GC, Liu X, Kim AJ, Lemke K, et al. Global genetic analysis in mice unveils central role for cilia in congenital heart disease. Nature. 2015;521(7553):520\u20134. https:\/\/doi.org\/10.1038\/nature14269.","journal-title":"Nature"},{"issue":"5","key":"2090_CR34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/pr.2014.17","volume":"75","author":"J Zhang","year":"2014","unstructured":"Zhang J, Ma X, Wang H, Ma D, Huang G. Elevated methylation of the RXRA promoter region may be responsible for its downregulated expression in the myocardium of patients with TOF. Pediatr Res. 2014;75(5):588\u201394. https:\/\/doi.org\/10.1038\/pr.2014.17.","journal-title":"Pediatr Res"},{"issue":"3","key":"2090_CR35","doi-asserted-by":"publisher","first-page":"e0200229","DOI":"10.1371\/journal.pone.0200229","volume":"14","author":"U Radhakrishna","year":"2019","unstructured":"Radhakrishna U, Albayrak S, Zafra R, Baraa A, Vishweswaraiah S, Veerappa AM, et al. Placental epigenetics for evaluation of fetal congenital heart defects: ventricular septal defect (VSD). PLoS ONE. 2019;14(3):e0200229. https:\/\/doi.org\/10.1371\/journal.pone.0200229.","journal-title":"PLoS ONE"},{"issue":"10","key":"2090_CR36","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1038\/emm.2017.150","volume":"49","author":"J Xiao","year":"2017","unstructured":"Xiao J, Liu H, Cretoiu D, Toader DO, Suciu N, Shi J, et al. miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1. Exp Mol Med. 2017;49(10):e386. https:\/\/doi.org\/10.1038\/emm.2017.150.","journal-title":"Exp Mol Med"},{"key":"2090_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1479-5876-12-31","volume":"12","author":"W Sheng","year":"2014","unstructured":"Sheng W, Qian Y, Zhang P, Wu Y, Wang H, Ma X, et al. Association of promoter methylation statuses of congenital heart defect candidate genes with Tetralogy of Fallot. J translational Med. 2014;12:31. https:\/\/doi.org\/10.1186\/1479-5876-12-31.","journal-title":"J translational Med"},{"issue":"1","key":"2090_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12920-020-00848-0","volume":"14","author":"S Chang","year":"2021","unstructured":"Chang S, Wang Y, Xin Y, Wang S, Luo Y, Wang L, et al. DNA methylation abnormalities of imprinted genes in congenital heart disease: a pilot study. BMC Med Genom. 2021;14(1):4. https:\/\/doi.org\/10.1186\/s12920-020-00848-0.","journal-title":"BMC Med Genom"},{"issue":"11","key":"2090_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-018-0100-2","volume":"15","author":"D MacGrogan","year":"2018","unstructured":"MacGrogan D, M\u00fcnch J, de la Pompa JL. Notch and interacting signalling pathways in cardiac development, disease, and regeneration. Nat reviews Cardiol. 2018;15(11):685\u2013704. https:\/\/doi.org\/10.1038\/s41569-018-0100-2.","journal-title":"Nat reviews Cardiol"},{"issue":"17","key":"2090_CR40","doi-asserted-by":"publisher","first-page":"9898","DOI":"10.1111\/jcmm.15584","volume":"24","author":"X Zhao","year":"2020","unstructured":"Zhao X, Chang S, Liu X, Wang S, Zhang Y, Lu X, et al. Imprinting aberrations of SNRPN, ZAC1 and INPP5F genes involved in the pathogenesis of congenital heart disease with extracardiac malformations. J Cell Mol Med. 2020;24(17):9898\u2013907. https:\/\/doi.org\/10.1111\/jcmm.15584.","journal-title":"J Cell Mol Med"},{"key":"2090_CR41","doi-asserted-by":"publisher","unstructured":"Pinto NM, Keenan HT, Minich LL, Puchalski MD, Heywood M, Botto LD. Barriers to prenatal detection of congenital heart disease: a population-based study. Ultrasound in obstetrics & gynecology. Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2012;40(4):418\u201325. https:\/\/doi.org\/10.1002\/uog.10116","DOI":"10.1002\/uog.10116"},{"issue":"2","key":"2090_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ije\/dyz009","volume":"48","author":"Y Liu","year":"2019","unstructured":"Liu Y, Chen S, Z\u00fchlke L, Black GC, Choy MK, Li N, et al. Global birth prevalence of congenital heart defects 1970\u20132017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455\u201363. https:\/\/doi.org\/10.1093\/ije\/dyz009.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"2090_CR43","doi-asserted-by":"publisher","first-page":"e025163","DOI":"10.1161\/jaha.121.025163","volume":"11","author":"G Wang","year":"2022","unstructured":"Wang G, Wang B, Yang P. Epigenetics in congenital heart disease. J Am Heart Association. 2022;11(7):e025163. https:\/\/doi.org\/10.1161\/jaha.121.025163.","journal-title":"J Am Heart Association"},{"issue":"16","key":"2090_CR44","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1093\/cvr\/cvae203","volume":"120","author":"K Cai","year":"2024","unstructured":"Cai K, Wang F, Shi HQ, Shen AN, Zhao R, Geng HR, et al. Maternal folic acid over-supplementation impairs cardiac function in mice offspring by inhibiting SOD1 expression. Cardiovascular Res. 2024;120(16):2092\u2013103. https:\/\/doi.org\/10.1093\/cvr\/cvae203.","journal-title":"Cardiovascular Res"},{"issue":"2","key":"2090_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ijgo.12373","volume":"140","author":"CL van Velzen","year":"2018","unstructured":"van Velzen CL, Ket JCF, van de Ven PM, Blom NA, Haak MC. Systematic review and meta-analysis of the performance of second-trimester screening for prenatal detection of congenital heart defects. Int J Gynaecol Obstet. 2018;140(2):137\u201345. https:\/\/doi.org\/10.1002\/ijgo.12373.","journal-title":"Int J Gynaecol Obstet"},{"key":"2090_CR46","doi-asserted-by":"publisher","unstructured":"van Nisselrooij AEL, Teunissen AKK, Clur SA, Rozendaal L, Pajkrt E, Linskens IH, et al. Why are congenital heart defects being missed? Ultrasound in obstetrics & gynecology. J Int Soc Ultrasound Obstet Gynecol. 2020;55(6):747\u201357. https:\/\/doi.org\/10.1002\/uog.20358.","DOI":"10.1002\/uog.20358"},{"key":"2090_CR47","doi-asserted-by":"publisher","first-page":"671191","DOI":"10.3389\/fcvm.2021.671191","volume":"8","author":"Y Li","year":"2021","unstructured":"Li Y, Sun Y, Yang L, Huang M, Zhang X, Wang X, et al. Analysis of biomarkers for congenital heart disease based on maternal amniotic fluid metabolomics. Front Cardiovasc Med. 2021;8:671191. https:\/\/doi.org\/10.3389\/fcvm.2021.671191.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"2090_CR48","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1021\/acs.jproteome.8b00466","volume":"17","author":"M Yu","year":"2018","unstructured":"Yu M, Sun S, Yu J, Du F, Zhang S, Yang W, et al. Discovery and validation of potential serum biomarkers for pediatric patients with congenital heart diseases by metabolomics. J Proteome Res. 2018;17(10):3517\u201325. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00466.","journal-title":"J Proteome Res"},{"issue":"2","key":"2090_CR49","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1542\/peds.2014-3783","volume":"136","author":"MD Quartermain","year":"2015","unstructured":"Quartermain MD, Pasquali SK, Hill KD, Goldberg DJ, Huhta JC, Jacobs JP, et al. Variation in prenatal diagnosis of congenital heart disease in infants. Pediatrics. 2015;136(2):e378\u201385. https:\/\/doi.org\/10.1542\/peds.2014-3783.","journal-title":"Pediatrics"},{"key":"2090_CR50","doi-asserted-by":"publisher","unstructured":"Habashi JP, MacFarlane EG, Bagirzadeh R, Bowen C, Huso N, Chen Y, et al. Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome. Sci Transl Med. 2019;11(490). https:\/\/doi.org\/10.1126\/scitranslmed.aat4822.","DOI":"10.1126\/scitranslmed.aat4822"},{"key":"2090_CR51","doi-asserted-by":"publisher","first-page":"120244","DOI":"10.1016\/j.lfs.2021.120244","volume":"289","author":"B Yu","year":"2022","unstructured":"Yu B, Yao S, Liu L, Li H, Zhu J, Li M, et al. The role of polypeptide PDTLN1 in suppression of PI3K\/AKT signaling causes cardiogenetic disorders in vitro and in vivo. Life Sci. 2022;289:120244. https:\/\/doi.org\/10.1016\/j.lfs.2021.120244.","journal-title":"Life Sci"},{"issue":"2","key":"2090_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.16288\/j.yczz.18-293","volume":"41","author":"ZY Liu","year":"2019","unstructured":"Liu ZY, Huang X, Li ZY, Yang ZH, Yuan BY. [The role of actin cytoskeleton in regulating the deployment process of mouse cardiac second heart field progenitor cells]. Yi chuan = Hereditas. 2019;41(2):125\u201336. https:\/\/doi.org\/10.16288\/j.yczz.18-293.","journal-title":"Yi chuan = Hereditas"},{"key":"2090_CR53","doi-asserted-by":"publisher","unstructured":"Paudel S, Sindelar R, Saha M. Calcium signaling in vertebrate development and its role in disease. Int J Mol Sci. 2018;19(11). https:\/\/doi.org\/10.3390\/ijms19113390.","DOI":"10.3390\/ijms19113390"},{"issue":"1","key":"2090_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40246-019-0250-2","volume":"13","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yu Q, Mao X, Lei W, He M, Lu W. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions\/microduplications in a cohort of 42,910 single pregnancies with different clinical features. Hum Genomics. 2019;13(1):60. https:\/\/doi.org\/10.1186\/s40246-019-0250-2.","journal-title":"Hum Genomics"},{"issue":"2","key":"2090_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.stem.2018.06.014","volume":"23","author":"TS Barakat","year":"2018","unstructured":"Barakat TS, Halbritter F, Zhang M, Rendeiro AF, Perenthaler E, Bock C, et al. Functional dissection of the enhancer repertoire in human embryonic stem cells. Cell Stem Cell. 2018;23(2):276\u2013. https:\/\/doi.org\/10.1016\/j.stem.2018.06.014.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2090_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tig.2015.03.002","volume":"31","author":"G Lev Maor","year":"2015","unstructured":"Lev Maor G, Yearim A, Ast G. The alternative role of DNA methylation in splicing regulation. Trends Genet. 2015;31(5):274\u201380. https:\/\/doi.org\/10.1016\/j.tig.2015.03.002.","journal-title":"Trends Genet"},{"issue":"7","key":"2090_CR57","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484\u201392. https:\/\/doi.org\/10.1038\/nrg3230.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2090_CR58","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11427-018-9329-3","volume":"62","author":"L Meng","year":"2019","unstructured":"Meng L, Tu C, Lu G, Lin G, Tan Y. Novel biallelic PCNT deletion causing microcephalic osteodysplastic primordial dwarfism type II with congenital heart defect. Sci China Life Sci. 2019;62(1):144\u20137. https:\/\/doi.org\/10.1007\/s11427-018-9329-3.","journal-title":"Sci China Life Sci"},{"issue":"10","key":"2090_CR59","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1242\/dev.034157","volume":"136","author":"AD Hoffmann","year":"2009","unstructured":"Hoffmann AD, Peterson MA, Friedland-Little JM, Anderson SA, Moskowitz IP. sonic hedgehog is required in pulmonary endoderm for atrial septation. Development. 2009;136(10):1761\u201370. https:\/\/doi.org\/10.1242\/dev.034157.","journal-title":"Development"},{"issue":"5","key":"2090_CR60","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.devcel.2007.03.004","volume":"12","author":"T Caspary","year":"2007","unstructured":"Caspary T, Larkins CE, Anderson KV. The graded response to Sonic Hedgehog depends on cilia architecture. Dev Cell. 2007;12(5):767\u201378. https:\/\/doi.org\/10.1016\/j.devcel.2007.03.004.","journal-title":"Dev Cell"},{"issue":"2","key":"2090_CR61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1083\/jcb.200908114","volume":"188","author":"B Delaval","year":"2010","unstructured":"Delaval B, Doxsey SJ. Pericentrin in cellular function and disease. J Cell Biol. 2010;188(2):181\u201390. https:\/\/doi.org\/10.1083\/jcb.200908114.","journal-title":"J Cell Biol"},{"issue":"9","key":"2090_CR62","doi-asserted-by":"publisher","first-page":"102608","DOI":"10.1016\/j.stemcr.2025.102608","volume":"20","author":"S Byeon","year":"2025","unstructured":"Byeon S, Ferreccio A, Cornell M, Oses-Prieto JA, Deshpande A, Manvi S, et al. TAOK2 drives opposing cilia length deficits in 16p11.2 deletion and duplication carriers. Stem cell Rep. 2025;20(9):102608. https:\/\/doi.org\/10.1016\/j.stemcr.2025.102608.","journal-title":"Stem cell Rep"},{"issue":"5815","key":"2090_CR63","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.1136352","volume":"315","author":"A Hellman","year":"2007","unstructured":"Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Sci (New York NY). 2007;315(5815):1141\u20133. https:\/\/doi.org\/10.1126\/science.1136352.","journal-title":"Sci (New York NY)"},{"issue":"4","key":"2090_CR64","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00404-024-07698-6","volume":"310","author":"Y Gofin","year":"2024","unstructured":"Gofin Y, Svirsky R, Lavi Ben Atav D, Liberman M, Tenne T, Perlman S, et al. DNA concentrations in amniotic fluid according to gestational age and fetal sex: data from 2573 samples. Arch Gynecol Obstet. 2024;310(4):1981\u20137. https:\/\/doi.org\/10.1007\/s00404-024-07698-6.","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"2090_CR65","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3109\/14653249.2010.547466","volume":"13","author":"JM Miranda-Sayago","year":"2011","unstructured":"Miranda-Sayago JM, Fern\u00e1ndez-Arcas N, Benito C, Reyes-Engel A, Carrera J, Alonso A. Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells. Cytotherapy. 2011;13(5):572\u201381. https:\/\/doi.org\/10.3109\/14653249.2010.547466.","journal-title":"Cytotherapy"},{"issue":"4","key":"2090_CR66","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","volume":"26","author":"X Yang","year":"2014","unstructured":"Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 2014;26(4):577\u201390. https:\/\/doi.org\/10.1016\/j.ccr.2014.07.028.","journal-title":"Cancer Cell"},{"issue":"2","key":"2090_CR67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ogc.2017.02.004","volume":"44","author":"LM Carlson","year":"2017","unstructured":"Carlson LM, Vora NL. Prenatal diagnosis: screening and diagnostic tools. Obstet Gynecol Clin N Am. 2017;44(2):245\u2013. https:\/\/doi.org\/10.1016\/j.ogc.2017.02.004. \u200956.","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"4","key":"2090_CR68","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.tjog.2021.05.018","volume":"60","author":"M Goto","year":"2021","unstructured":"Goto M, Nakamura M, Takita H, Sekizawa A. Study for risks of amniocentesis in anterior placenta compared to placenta of other locations. Taiwan J Obstet Gynecol. 2021;60(4):690\u20134. https:\/\/doi.org\/10.1016\/j.tjog.2021.05.018.","journal-title":"Taiwan J Obstet Gynecol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02090-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02090-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02090-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:17:24Z","timestamp":1775035044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02090-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2090"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02090-4","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Human Research of Women and Children\u2019s Hospital, School of Medicine, Xiamen University (ID: KY-2019-065), and all participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}